About this Journal Submit a Manuscript Table of Contents
Journal of Nutrition and Metabolism
Volume 2013 (2013), Article ID 285948, 16 pages
http://dx.doi.org/10.1155/2013/285948
Review Article

Potential Mechanisms of Exercise in Gestational Diabetes

Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada V6T 1Z3

Received 25 September 2012; Revised 31 January 2013; Accepted 10 February 2013

Academic Editor: Peter M. Clifton

Copyright © 2013 Saeid Golbidi and Ismail Laher. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Canadian Diabetes Association Clinical Practice Guidelines Expert Committee: Canadian Diabetes Association clinical practice guidelines for the prevention and management of diabetes in Canada,” Canadian Journal of Diabetes, vol. 27, pp. S99–S105, 2003.
  2. American Diabetes Association, “Gestational diabetes mellitus,” Diabetes Care, vol. 27, pp. S88–S90, 2004.
  3. K. G. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998.
  4. E. A. Reece, C. Homko, M. Miodovnik, and O. Langer, “A consensus report of the Diabetes in Pregnancy Study Group of North America conference: little Rock, Arkansas, May 2002,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 12, no. 6, pp. 362–364, 2002. View at Scopus
  5. R. Artal, “Exercise: the alternative therapeutic intervention for gestational diabetes,” Clinical Obstetrics and Gynecology, vol. 46, no. 2, pp. 479–487, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Kühl, “Etiology and pathogenesis of gestational diabetes,” Diabetes Care, vol. 21, no. 2, pp. B19–B26, 1998. View at Scopus
  7. A. T. Blanco, S. W. Semilen, Y. Davis, S. Lopez, R. Lapinski, and C. J. Lockwood, “Pregnancy outcome and weight gain recommendations for the morbidly obese women,” Obstetrics and Gynecology, vol. 91, no. 1, pp. 97–102, 1998.
  8. Y. Linné, “Effects of obesity on women's reproduction and complications during pregnancy,” Obesity Reviews, vol. 5, no. 3, pp. 137–143, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. HAPO Study Cooperative Research Group, “Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index,” An International Journal of Obstetrics and Gynaecology, vol. 117, no. 5, pp. 575–584, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Getahun, C. Nath, C. V. Ananth, M. R. Chavez, and J. C. Smulian, “Gestational diabetes in the United States: temporal trends 1989 through 2004,” American Journal of Obstetrics and Gynecology, vol. 198, no. 5, pp. 525.e1–525.e5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. American Diabetes Association, “Standards of medical care in diabetes-2009,” Diabetes Care, vol. 32, no. supplement 1, pp. S13–S61, 2009.
  12. S. Schneider, C. Bock, M. Wetzel, H. Maul, and A. Loerbroks, “The prevalence of gestational diabetes in advanced economies,” Journal of Perinatal Medicine, vol. 40, no. 5, pp. 511–520, 2012. View at Publisher · View at Google Scholar
  13. M. J. Paglia and D. R. Coustan, “Gestational diabetes: evolving diagnostic criteria,” Current Opinion in Obstetrics and Gynecology, vol. 23, pp. 72–75, 2011. View at Publisher · View at Google Scholar
  14. “Canadian Diabetes Association Clinical Practice Guidelines Expert Committee,” Canadian Diabetes Association, vol. 32, pp. S1–S201, 2008.
  15. S. Y. Chu, W. M. Callaghan, S. Y. Kim et al., “Maternal obesity and risk of gestational diabetes mellitus,” Diabetes Care, vol. 30, no. 8, pp. 2070–2076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. R. Torloni, A. P. Betrán, B. L. Horta et al., “Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis: diagnostic in Obesity and Complications,” Obesity Reviews, vol. 10, no. 2, pp. 194–203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. M. Schlüssel, E. B. De Souza, M. E. Reichenheim, and G. Kac, “Physical activity during pregnancy and maternal-child health outcomes: a systematic literature review,” Cadernos de Saude Publica, vol. 24, no. 4, pp. S531–S544, 2008. View at Scopus
  18. J. C. Dempsey, C. L. Butler, and M. A. Williams, “No need for a pregnant pause: physical activity may reduce the occurrence of gestational diabetes mellitus and preeclampsia,” Exercise and Sport Sciences Reviews, vol. 33, no. 3, pp. 141–149, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. “ACOG Committee opinion. Number 267, January 2002: exercise during pregnancy and the postpartum period,” Obstetrics & Gynecology, vol. 99, no. 1, pp. 171–173, 2002.
  20. American Diabetes Association, “Gestational diabetes mellitus,” Diabetes Care, vol. 26, pp. S103–S105, 2003.
  21. B. E. Metzger, T. A. Buchanan, D. R. Coustan, et al., “Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus,” Diabetes Care, vol. 30, no. supplement 2, pp. s251–s260, 2007. View at Publisher · View at Google Scholar
  22. T. A. Buchanan, A. Xiang, S. L. Kjos, and R. Watanabe, “What is gestational diabetes?” Diabetes Care, vol. 30, no. 2, pp. S105–S111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. P. M. Catalano, E. D. Tzybir, R. R. Wolfe, et al., “Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes,” American Journal of Physiology, vol. 264, pp. E60–E67, 1993.
  24. T. A. Buchanan and A. H. Xiang, “Gestational diabetes mellitus,” Journal of Clinical Investigation, vol. 115, no. 3, pp. 485–491, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Y. Lain and P. M. Catalano, “Metabolic changes in pregnancy,” Clinical Obstetrics and Gynecology, vol. 50, no. 4, pp. 938–948, 2007.
  26. J. P. Kirwan, S. Hauguel-De Mouzon, J. Lepercq et al., “TNF-α is a predictor of insulin resistance in human pregnancy,” Diabetes, vol. 51, no. 7, pp. 2207–2213, 2002. View at Scopus
  27. I. Falcão-Pires, P. Castro-Chaves, D. Miranda-Silva, A. P. Lourenço, and A. F. Leite-Moreira, “Physiological, pathological and potential therapeutic roles of adipokines,” Drug Discovery Today, vol. 17, pp. 880–889, 2012. View at Publisher · View at Google Scholar
  28. T. S. Tsao, H. E. Murrey, C. Hug, D. H. Lee, and H. F. Lodish, “Oligomerization state-dependent activation of NF-κB signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30),” Journal of Biological Chemistry, vol. 277, no. 33, pp. 29359–29362, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. U. B. Pajvani, X. Du, T. P. Combs et al., “Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: implications for metabolic regulation and bioactivity,” Journal of Biological Chemistry, vol. 278, no. 11, pp. 9073–9085, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Suzuki, E. M. Wilson-Kubalek, D. Wert, T. S. Tsao, and D. H. Lee, “The oligomeric structure of high molecular weight adiponectin,” FEBS Letters, vol. 581, no. 5, pp. 809–814, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. U. B. Pajvani, M. Hawkins, T. P. Combs et al., “Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity,” Journal of Biological Chemistry, vol. 279, no. 13, pp. 12152–12162, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. D. K. Oh, T. Ciaraldi, and R. R. Henry, “Adiponectin in health and disease,” Diabetes, Obesity and Metabolism, vol. 9, no. 3, pp. 282–289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Rizza, F. Gigli, A. Galli et al., “Adiponectin isoforms in elderly patients with or without coronary artery disease,” Journal of the American Geriatrics Society, vol. 58, no. 4, pp. 702–706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Almeda-Valdes, D. Cuevas-Ramos, R. Mehta et al., “Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance,” Cardiovascular Diabetology, vol. 9, article 26, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Mazaki-Tovi, H. Kanety, and E. Sivan, “Adiponectin and human pregnancy,” Current Diabetes Reports, vol. 5, no. 4, pp. 278–281, 2005. View at Scopus
  36. W. S. Yang, W. J. Lee, T. Funahashi et al., “Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 8, pp. 3815–3819, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Mavri, P. Poredoš, D. Šuran, B. Gaborit, I. Juhan-Vague, and P. Poredoš, “Effect of diet-induced weight loss on endothelial dysfunction: early improvement after the first week of dieting,” Heart and Vessels, vol. 26, no. 1, pp. 31–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Ohashi, N. Ouchi, and Y. Matsuzawa, “Anti-inflammatory and anti-atherogenic properties of adiponectin,” Biochimie, vol. 94, pp. 2137–2142, 2012. View at Publisher · View at Google Scholar
  39. G. Musso, R. Gambino, G. Biroli et al., “Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis,” American Journal of Gastroenterology, vol. 100, no. 11, pp. 2438–2446, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Retnakaran, A. J. G. Hanley, N. Raif et al., “Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications,” Diabetologia, vol. 48, no. 5, pp. 993–1001, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Ouchi, S. Kihara, Y. Arita et al., “Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway,” Circulation, vol. 102, no. 11, pp. 1296–1301, 2000. View at Scopus
  42. T. Yokota, K. Oritani, I. Takahashi et al., “Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages,” Blood, vol. 96, no. 5, pp. 1723–1732, 2000. View at Scopus
  43. D. Cortelazzi, S. Corbetta, S. Ronzoni et al., “Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies,” Clinical Endocrinology, vol. 66, no. 3, pp. 447–453, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Mazaki-Tovi, H. Kanety, C. Pariente et al., “Maternal serum adiponectin levels during human pregnancy,” Journal of Perinatology, vol. 27, no. 2, pp. 77–81, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. J. O'Sullivan, A. D. Kriketos, A. Martin, and M. A. Brown, “Serum adiponectin levels in normal and hypertensive pregnancy,” Hypertension in Pregnancy, vol. 25, no. 3, pp. 193–203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. T. F. Chan, S. S. F. Yuan, H. S. Chen et al., “Correlations between umbilical and maternal serum adiponectin levels and neonatal birthweights,” Acta Obstetricia et Gynecologica Scandinavica, vol. 83, no. 2, pp. 165–169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Chen, B. Tan, E. Karteris et al., “Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines,” Diabetologia, vol. 49, no. 6, pp. 1292–1302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Haugen, T. Ranheim, N. K. Harsem, E. Lips, A. C. Staff, and C. A. Drevon, “Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression,” American Journal of Physiology, vol. 290, no. 2, pp. E326–E333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Worda, H. Leipold, C. Gruber, A. Kautzky-Willer, M. Knöfler, and D. Bancher-Todesca, “Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus,” American Journal of Obstetrics and Gynecology, vol. 191, no. 6, pp. 2120–2124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Cseh, E. Baranyi, Z. Melczer, E. Kaszás, E. Palik, and G. Winkler, “Plasma adiponectin and pregnancy-induced insulin resistance,” Diabetes Care, vol. 27, no. 1, pp. 274–275, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. M. A. Williams, C. Qiu, M. Muy-Rivera, S. Vadachkoria, T. Song, and D. A. Luthy, “Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 5, pp. 2306–2311, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Winzer, O. Wagner, A. Festa et al., “Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus,” Diabetes Care, vol. 27, no. 7, pp. 1721–1727, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. S. M. Heitritter, C. G. Solomon, G. F. Mitchell, N. Skali-Ounis, and E. W. Seely, “Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 7, pp. 3983–3988, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. H. C. Sung, H. K. Soo, B. S. Youn et al., “High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 8, pp. 3142–3148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Bełtowski, “Adiponectin and resistin—new hormones of white adipose tissue,” Medical Science Monitor, vol. 9, no. 2, pp. RA55–RA61, 2003. View at Scopus
  56. T. Yamauchi, J. Kamon, Y. Minokoshi, et al., “Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase,” Nature Medicine, vol. 8, pp. 1288–1295, 2002.
  57. T. Yamauchi, J. Kamon, H. Waki et al., “Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis,” Journal of Biological Chemistry, vol. 278, no. 4, pp. 2461–2468, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. A. E. Civitarese, B. Ukropcova, S. Carling et al., “Role of adiponectin in human skeletal muscle bioenergetics,” Cell Metabolism, vol. 4, no. 1, pp. 75–87, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. R. B. Ceddia, R. Somwar, A. Maida, X. Fang, G. Bikopoulos, and G. Sweeney, “Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells,” Diabetologia, vol. 48, no. 1, pp. 132–139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. R. A. Miller, Q. Chu, J. Le Lay et al., “Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling,” Journal of Clinical Investigation, vol. 121, no. 6, pp. 2518–2528, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Okamoto, M. Ohara-Imaizumi, N. Kubota et al., “Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration,” Diabetologia, vol. 51, no. 5, pp. 827–835, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Staiger, N. Stefan, H. Staiger et al., “Adiponectin is functionally active in human islets but does not affect insulin secretory function or β-cell lipoapoptosis,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 12, pp. 6707–6713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. M. S. Winzell, R. Nogueiras, C. Dieguez, and B. Ahrén, “Dual action of adiponectin on insulin secretion in insulin-resistant mice,” Biochemical and Biophysical Research Communications, vol. 321, no. 1, pp. 154–160, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. N. Wijesekara, M. Krishnamurthy, A. Bhattacharjee, A. Suhail, G. Sweeney, and M. B. Wheeler, “Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion,” Journal of Biological Chemistry, vol. 285, no. 44, pp. 33623–33631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. A. T. Turer and P. E. Scherer, “Adiponectin: mechanistic insights and clinical implications,” Diabetologia, vol. 55, no. 9, pp. 2319–2326, 2012. View at Publisher · View at Google Scholar
  66. A. M. Brennan and C. S. Mantzoros, “Drug Insight: the role of leptin in human physiology and pathophysiology—emerging clinical applications,” Nature Clinical Practice Endocrinology and Metabolism, vol. 2, no. 6, pp. 318–327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Ge, L. Huang, T. Pourbahrami, and C. Li, “Generation of soluble leptin receptor by ectodomain shedding of membrane-spanning receptors in vitro and in vivo,” Journal of Biological Chemistry, vol. 277, no. 48, pp. 45898–45903, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Yang and L. A. Barouch, “Leptin signaling and obesity: cardiovascular consequences,” Circulation Research, vol. 101, no. 6, pp. 545–559, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. S. H. Bates and M. G. Myers, “The role of leptin—STAT3 signaling in neuroendocrine function: an integrative perspective,” Journal of Molecular Medicine, vol. 82, no. 1, pp. 12–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Kloek, A. K. Haq, S. L. Dunn, H. J. Lavery, A. S. Banks, and M. G. Myers Jr., “Regulation of Jak kinases by intracellular leptin receptor sequences,” Journal of Biological Chemistry, vol. 277, no. 44, pp. 41547–41555, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. K. D. Niswender, B. Gallis, J. E. Blevins, M. A. Corson, M. W. Schwartz, and D. G. Baskin, “Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin,” Journal of Histochemistry and Cytochemistry, vol. 51, no. 3, pp. 275–283, 2003. View at Scopus
  72. H. Masuzaki, Y. Ogawa, N. Sagawa et al., “Nonadipose tissue production of leptin: leptin as a novel placenta- derived hormone in humans,” Nature Medicine, vol. 3, no. 9, pp. 1029–1033, 1997. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Hauguel-de Mouzon, J. Lepercq, and P. Catalano, “The known and unknown of leptin in pregnancy,” American Journal of Obstetrics and Gynecology, vol. 194, no. 6, pp. 1537–1545, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Wauters, R. V. Considine, and L. F. Van Gaal, “Human leptin: from an adipocyte hormone to an endocrine mediator,” European Journal of Endocrinology, vol. 143, no. 3, pp. 293–311, 2000. View at Scopus
  75. C. Grunfeld, C. Zhao, J. Fuller et al., “Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters: a role for leptin in the anorexia of infection,” Journal of Clinical Investigation, vol. 97, no. 9, pp. 2152–2157, 1996. View at Scopus
  76. P. J. Havel, S. Kasim-Karakas, W. Mueller, P. R. Johnson, R. L. Gingerich, and J. S. Stern, “Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 12, pp. 4406–4413, 1996. View at Publisher · View at Google Scholar · View at Scopus
  77. E. Jequier, “Leptin signaling, adiposity and energy balance,” Annals of the New York Academy of Sciences, vol. 967, pp. 379–388, 2002.
  78. C. Schubring, P. Englaro, T. Siebler et al., “Longitudinal analysis of maternal serum leptin levels during pregnancy, at birth and up to six weeks after birth: relation to body mass index, skinfolds, sex steroids and umbilical cord blood leptin levels,” Hormone Research, vol. 50, no. 5, pp. 276–283, 1998. View at Publisher · View at Google Scholar · View at Scopus
  79. H. Laivuori, R. Kaaja, H. Koistinen et al., “Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity,” Metabolism, vol. 49, no. 2, pp. 259–263, 2000. View at Scopus
  80. D. D. Briana and A. Malamitsi-Puchner, “Reviews: adipocytokines in normal and complicated pregnancies,” Reproductive Sciences, vol. 16, no. 10, pp. 921–937, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. E. Oteng-Ntim, R. Varma, H. Croker, L. Poston, and P. Doyle, “Lifestyle interventions for overweight and obese pregnant women to improve pregnancy outcome: systematic review and meta-analysis,” BMC Medicine, vol. 10, article 47, 2012. View at Publisher · View at Google Scholar
  82. S. L. Nascimento, F. G. Surita, and J. G. Cecatti, “Physical exercise during pregnancy: a systematic review,” Current Opinion in Obstetrics and Gynecology, vol. 24, no. 6, pp. 387–394, 2012. View at Publisher · View at Google Scholar
  83. J. M. Atègbo, O. Grissa, A. Yessoufou et al., “Modulation of adipokines and cytokines in gestational diabetes and macrosomia,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 10, pp. 4137–4143, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. T. J. Highman, J. E. Friedman, L. P. Huston, W. W. Wong, and P. M. Catalano, “Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy,” American Journal of Obstetrics and Gynecology, vol. 178, no. 5, pp. 1010–1015, 1998. View at Publisher · View at Google Scholar · View at Scopus
  85. M. C. Henson, K. F. Swan, and J. S. O'Neil, “Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term,” Obstetrics and Gynecology, vol. 92, no. 6, pp. 1020–1028, 1998. View at Publisher · View at Google Scholar · View at Scopus
  86. D. Chen, G. Xia, P. Xu, and M. Dong, “Peripartum serum leptin and soluble leptin receptor levels in women with gestational diabetes,” Acta Obstetricia et Gynecologica Scandinavica, vol. 89, no. 12, pp. 1595–1599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. C. Qiu, M. A. Williams, S. Vadachkoria, I. O. Frederick, and D. A. Luthy, “Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus,” Obstetrics and Gynecology, vol. 103, no. 3, pp. 519–525, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. X. L. Gao, H. X. Yang, and Y. Zhao, “Variations of tumor necrosis factor-α, leptin and adiponectin in mid-trimester of gestational diabetes mellitus,” Chinese Medical Journal, vol. 121, no. 8, pp. 701–705, 2008. View at Scopus
  89. R. D'Anna, G. Baviera, M. L. Cannata, A. De Vivo, A. Di Benedetto, and F. Corrado, “Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes,” Gynecologic and Obstetric Investigation, vol. 64, no. 2, pp. 65–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. R. G. Lea, D. Howe, L. T. Hannah, O. Bonneau, L. Hunter, and N. Hoggard, “Placental leptin in normal, diabetic and fetal growth-retarded pregnancies,” Molecular Human Reproduction, vol. 6, no. 8, pp. 763–769, 2000. View at Scopus
  91. M. A. Nuamah, S. Yura, N. Sagawa et al., “Significant increase in maternal plasma leptin concentration in induced delivery: a possible contribution of pro-inflammatory cytokines to placental leptin secretion,” Endocrine Journal, vol. 51, no. 2, pp. 177–187, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. L. A. Barbour, C. E. McCurdy, T. L. Hernandez, J. P. Kirwan, P. M. Catalano, and J. E. Friedman, “Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes,” Diabetes Care, vol. 30, no. 2, pp. S112–S119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. J. A. Gavard and R. Artal, “Effect of exercise on pregnancy outcome,” Clinical Obstetrics and Gynecology, vol. 51, pp. 467–480, 2008. View at Publisher · View at Google Scholar
  94. R. R. Banerjee and M. A. Lazar, “Dimerization of resistin and resistin-like molecules is determined by a single cysteine,” Journal of Biological Chemistry, vol. 276, no. 28, pp. 25970–25973, 2001. View at Publisher · View at Google Scholar · View at Scopus
  95. C. M. Steppan, S. T. Bailey, S. Bhat et al., “The hormone resistin links obesity to diabetes,” Nature, vol. 409, no. 6818, pp. 307–312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  96. P. G. McTernan, C. M. Kusminski, and S. Kumar, “Resistin,” Current Opinion in Lipidology, vol. 17, no. 2, pp. 170–175, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. E. Adeghate, “An update on the biology and physiology of resistin,” Cellular and Molecular Life Sciences, vol. 61, pp. 2485–2496, 2004.
  98. C. M. Steppan and M. A. Lazar, “The current biology of resistin,” Journal of Internal Medicine, vol. 255, no. 4, pp. 439–447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  99. K. Azuma, F. Katsukawa, S. Oguchi et al., “Correlation between serum resistin level and adiposity in obese individuals,” Obesity Research, vol. 11, no. 8, pp. 997–1001, 2003. View at Scopus
  100. J. V. Silha, M. Krsek, J. V. Skrha, P. Sucharda, B. L. G. Nyomba, and L. J. Murphy, “Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistence,” European Journal of Endocrinology, vol. 149, no. 4, pp. 331–335, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. K. M. Utzschneider, D. B. Carr, J. Tong et al., “Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans,” Diabetologia, vol. 48, no. 11, pp. 2330–2333, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. G. M. Dick, P. S. Katz, M. Farias III et al., “Resistin impairs endothelium-dependent dilation to bradykinin, but not acetylcholine, in the coronary circulation,” American Journal of Physiology, vol. 291, no. 6, pp. H2997–H3002, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. D. B. Savage, C. P. Sewter, E. S. Klenk et al., “Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator—activated receptor-γ action in humans,” Diabetes, vol. 50, no. 10, pp. 2199–2202, 2001. View at Scopus
  104. L. Patel, A. C. Buckels, I. J. Kinghorn et al., “Resistin is expressed in human macrophages and directly regulated by PPARγ activators,” Biochemical and Biophysical Research Communications, vol. 300, no. 2, pp. 472–476, 2003. View at Publisher · View at Google Scholar · View at Scopus
  105. D. Chen, M. Dong, Q. Fang, J. He, Z. Wang, and X. Yang, “Alterations of serum resistin in normal pregnancy and pre-eclampsia,” Clinical Science, vol. 108, no. 1, pp. 81–84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  106. S. Yura, N. Sagawa, H. Itoh et al., “Resistin is expressed in the human placenta,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 3, pp. 1394–1397, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. N. Di Simone, F. Di Nicuolo, D. Marzioni et al., “Resistin modulates glucose uptake and glucose transporter-1 (GLUT-1) expression in trophoblast cells,” Journal of Cellular and Molecular Medicine, vol. 13, no. 2, pp. 388–397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. E. Palik, E. Baranyi, Z. Melczer et al., “Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance,” Diabetes Research and Clinical Practice, vol. 76, no. 3, pp. 351–357, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Mazaki-Tovi, R. Romero, J. P. Kusanovic et al., “Maternal visfatin concentration in normal pregnancy,” Journal of Perinatal Medicine, vol. 37, no. 3, pp. 206–217, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. A. Megia, J. Vendrell, C. Gutierrez et al., “Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition,” European Journal of Endocrinology, vol. 158, no. 2, pp. 173–178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. M. Lappas, K. Yee, M. Permezel, and G. E. Rice, “Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies,” Journal of Endocrinology, vol. 186, no. 3, pp. 457–465, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. G. Winkler, K. Cseh, É. Baranyi et al., “Tumor necrosis factor system in insulin resistance in gestational diabetes,” Diabetes Research and Clinical Practice, vol. 56, no. 2, pp. 93–99, 2002. View at Publisher · View at Google Scholar · View at Scopus
  113. G. S. Hotamisligil, D. L. Murray, L. N. Choy, and B. M. Spiegelman, “Tumor necrosis factor alpha inhibits signaling from the insulin receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, pp. 4854–4858, 1994.
  114. R. Feinstein, H. Kanety, M. Z. Papa, B. Lunenfeld, and A. Karasik, “Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates,” Journal of Biological Chemistry, vol. 268, no. 35, pp. 26055–26058, 1993. View at Scopus
  115. L. F. del Aguila, K. P. Claffey, and J. P. Kirwan, “TNF-α impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells,” American Journal of Physiology, vol. 276, no. 5, pp. E849–E855, 1999. View at Scopus
  116. G. S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M. F. White, and B. M. Spiegelman, “IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance,” Science, vol. 271, no. 5249, pp. 665–668, 1996. View at Scopus
  117. J. P. Kirwan, R. K. Krishnan, J. A. Weaver, L. F. del Aguila, and W. J. Evans, “Human aging is associated with altered TNF-α production during hyperglycemia and hyperinsulinemia,” American Journal of Physiology, vol. 281, no. 6, pp. E1137–E1143, 2001. View at Scopus
  118. P. R. Ling, B. R. Bistrian, B. Mendez, and N. W. Istfan, “Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: relationship to endogenous glucose production and peripheral tissue glucose uptake,” Metabolism, vol. 43, no. 3, pp. 279–284, 1994. View at Publisher · View at Google Scholar · View at Scopus
  119. L. F. del Aguila, R. K. Krishnan, J. S. Ulbrecht et al., “Muscle damage impairs insulin stimulation of IRS-1, PI 3-kinase, and Akt-kinase in human skeletal muscle,” American Journal of Physiology, vol. 279, no. 1, pp. E206–E212, 2000. View at Scopus
  120. M. T. Coughlan, K. Oliva, H. M. Georgiou, J. M. H. Permezel, and G. E. Rice, “Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus,” Diabetic Medicine, vol. 18, no. 11, pp. 921–927, 2001. View at Publisher · View at Google Scholar · View at Scopus
  121. K. A. McLachlan, D. O'Neal, A. Jenkins, and F. P. Alford, “Do adiponectin, TNFα, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with or without gestational diabetes, during and after pregnancy,” Diabetes/Metabolism Research and Reviews, vol. 22, no. 2, pp. 131–138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  122. A. Fukuhara, M. Matsuda, M. Nishizawa et al., “Visfatin: a protein secreted by visceral fat that Mimics the effects of insulin,” Science, vol. 307, no. 5708, pp. 426–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  123. T. D. Filippatos, C. S. Derdemezis, I. F. Gazi et al., “Increased plasma visfatin levels in subjects with the metabolic syndrome,” European Journal of Clinical Investigation, vol. 38, no. 1, pp. 71–72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  124. M. P. Chen, F. M. Chung, D. M. Chang et al., “Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 1, pp. 295–299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  125. J. Berndt, N. Klöting, S. Kralisch et al., “Plasma visfatin concentrations and fat depot-specific mRNA expression in humans,” Diabetes, vol. 54, no. 10, pp. 2911–2916, 2005. View at Publisher · View at Google Scholar · View at Scopus
  126. S. A. Morgan, J. B. Bringolf, and E. R. Seidel, “Visfatin expression is elevated in normal human pregnancy,” Peptides, vol. 29, no. 8, pp. 1382–1389, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. B. Telejko, M. Kuzmicki, A. Zonenberg et al., “Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue,” Diabetes Research and Clinical Practice, vol. 84, no. 1, pp. 68–75, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. S. Ognjanovic, T. L. Ku, and G. D. Bryant-Greenwood, “Pre-B-cell colony-enhancing factor is a secreted cytokine-like protein from the human amniotic epithelium,” American Journal of Obstetrics and Gynecology, vol. 193, no. 1, pp. 273–282, 2005. View at Publisher · View at Google Scholar · View at Scopus
  129. T. Josephs, H. Waugh, I. Kokay, D. Grattan, and M. Thompson, “Fasting-induced adipose factor identified as a key adipokine that is up-regulated in white adipose tissue during pregnancy and lactation in the rat,” Journal of Endocrinology, vol. 194, no. 2, pp. 305–312, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. D. D. Briana, M. Boutsikou, D. Gourgiotis et al., “Role of visfatin, insulin-like growth factor-I and insulin in fetal growth,” Journal of Perinatal Medicine, vol. 35, no. 4, pp. 326–329, 2007. View at Publisher · View at Google Scholar · View at Scopus
  131. K. C. Lewandowski, N. Stojanovic, M. Press et al., “Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance,” Diabetologia, vol. 50, no. 5, pp. 1033–1037, 2007. View at Publisher · View at Google Scholar · View at Scopus
  132. K. Krzyzanowska, W. Krugluger, F. Mittermayer et al., “Increased visfatin concentrations in women with gestational diabetes mellitus,” Clinical Science, vol. 110, no. 5, pp. 605–609, 2006. View at Publisher · View at Google Scholar · View at Scopus
  133. S. Mazaki-Tovi, R. Romero, J. P. Kusanovic et al., “Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight,” Journal of Perinatal Medicine, vol. 37, no. 3, pp. 218–231, 2009. View at Publisher · View at Google Scholar · View at Scopus
  134. T. F. Chan, Y. L. Chen, C. H. Lee et al., “Decreased plasma visfatin concentrations in women with gestational diabetes mellitus,” Journal of the Society for Gynecologic Investigation, vol. 13, no. 5, pp. 364–367, 2006. View at Publisher · View at Google Scholar · View at Scopus
  135. D. G. Haider, A. Handisurya, A. Storka et al., “Visfatin response to glucose is reduced in women with gestational diabetes mellitus,” Diabetes Care, vol. 30, no. 7, pp. 1889–1891, 2007. View at Publisher · View at Google Scholar · View at Scopus
  136. M. Akturk, A. E. Altinova, I. Mert et al., “Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester,” Journal of Endocrinological Investigation, vol. 31, no. 7, pp. 610–613, 2008. View at Scopus
  137. G. Mastorakos, G. Valsamakis, D. C. Papatheodorou et al., “The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity,” Clinical Chemistry, vol. 53, no. 8, pp. 1477–1483, 2007. View at Publisher · View at Google Scholar · View at Scopus
  138. S. Ognjanovic, L. S. Tashima, and G. D. Bryant-Greenwood, “The effects of pre-B-cell colony-enhancing factor on the human fetal membranes by microarray analysis,” American Journal of Obstetrics and Gynecology, vol. 189, no. 4, pp. 1187–1195, 2003. View at Publisher · View at Google Scholar · View at Scopus
  139. B. Masri, N. Morin, L. Pedebernade, B. Knibiehler, and Y. Audigier, “The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments,” Journal of Biological Chemistry, vol. 281, no. 27, pp. 18317–18326, 2006. View at Publisher · View at Google Scholar · View at Scopus
  140. M. De Falco, L. De, N. Onori et al., “Apelin expression in normal human tissues,” In Vivo, vol. 16, no. 5, pp. 333–336, 2002. View at Scopus
  141. S. Rayalam, M. A. Della-Fera, P. A. Krieg, C. M. Cox, A. Robins, and C. A. Baile, “A putative role for apelin in the etiology of obesity,” Biochemical and Biophysical Research Communications, vol. 368, no. 3, pp. 815–819, 2008. View at Publisher · View at Google Scholar · View at Scopus
  142. O. Kunduzova, N. Alet, N. Delesque-Touchard et al., “Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes,” The FASEB Journal, vol. 22, no. 12, pp. 4146–4153, 2008. View at Publisher · View at Google Scholar · View at Scopus
  143. J. Bełtowski, “Apelin and visfatin: unique “beneficial” adipokines up regulated in obesity?” Medical Science Monitor, vol. 12, pp. RA112–RA119, 2006. View at Scopus
  144. K. Tatemoto, K. Takayama, M. X. Zou et al., “The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism,” Regulatory Peptides, vol. 99, no. 2-3, pp. 87–92, 2001. View at Publisher · View at Google Scholar · View at Scopus
  145. L. Cobellis, M. De Falco, A. Mastrogiacomo et al., “Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas,” Histology and Histopathology, vol. 22, no. 1–3, pp. 1–8, 2007. View at Scopus
  146. C. M. Cox, S. L. D'Agostino, M. K. Miller, R. L. Heimark, and P. A. Krieg, “Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo,” Developmental Biology, vol. 296, no. 1, pp. 177–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  147. M. Aslan, O. Celik, N. Celik, et al., “Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus,” Endocrine, vol. 41, pp. 424–429, 2012. View at Publisher · View at Google Scholar
  148. B. A. Zabel, A. M. Silverio, and E. C. Butcher, “Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood,” Journal of Immunology, vol. 174, no. 1, pp. 244–251, 2005. View at Scopus
  149. V. Wittamer, J. D. Franssen, M. Vulcano et al., “Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids,” Journal of Experimental Medicine, vol. 198, no. 7, pp. 977–985, 2003. View at Publisher · View at Google Scholar · View at Scopus
  150. S. Kralisch, S. Weise, G. Sommer et al., “Interleukin-1ß induces the novel adipokine chemerin in adipocytes in vitro,” Regulatory Peptides, vol. 154, no. 1–3, pp. 102–106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  151. K. Bozaoglu, K. Bolton, J. McMillan et al., “Chemerin is a novel adipokine associated with obesity and metabolic syndrome,” Endocrinology, vol. 148, no. 10, pp. 4687–4694, 2007. View at Publisher · View at Google Scholar · View at Scopus
  152. J. F. Clapp III and W. Kiess, “Effects of pregnancy and exercise on concentrations of the metabolic markers tumor necrosis factor α and leptin,” American Journal of Obstetrics and Gynecology, vol. 182, no. 2, pp. 300–306, 2000. View at Scopus
  153. D. Pfau, H. Stepan, J. Kratzsch et al., “Circulating levels of the adipokine chemerin in gestational diabetes mellitus,” Hormone Research in Paediatrics, vol. 74, no. 1, pp. 56–61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  154. G. Barker, R. Lim, G. E. Rice, and M. Lappas, “Increased chemerin concentrations in fetuses of obese mothers and correlation with maternal insulin sensitivity,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 25, pp. 2274–2280, 2012. View at Publisher · View at Google Scholar
  155. G. Ceysens, D. Rouiller, and M. Boulvain, “Exercise for diabetic pregnant women,” Cochrane Database of Systematic Reviews, vol. 3, p. CD004225, 2006. View at Scopus
  156. S. Han, P. Middleton, and C. A. Crowther, “Exercise for pregnant women for preventing gestational diabetes mellitus,” Cochrane Database of Systematic Reviews, vol. 11, no. 7, Article ID CD009021, 2012. View at Publisher · View at Google Scholar
  157. D. K. Tobias, C. Zhang, R. M. van Dam, K. Bowers, and F. B. Hu, “Physical activity before and during pregnancy and risk of gestational diabetes mellitus: a meta-analysis,” Diabetes Care, vol. 34, no. 1, pp. 223–229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  158. J. C. Dempsey, C. L. Butler, T. K. Sorensen et al., “A case-control study of maternal recreational physical activity and risk of gestational diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 66, no. 2, pp. 203–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  159. C. Zhang, C. G. Solomon, J. E. Manson, and F. B. Hu, “A prospective study of pregravid physical activity and sedentary behaviors in relation to the risk for gestational diabetes mellitus,” Archives of Internal Medicine, vol. 166, no. 5, pp. 543–548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  160. E. Oken, Y. Ning, S. L. Rifas-Shiman, J. S. Radesky, J. W. Rich-Edwards, and M. W. Gillman, “Associations of physical activity and inactivity before and during pregnancy with glucose tolerance,” Obstetrics and Gynecology, vol. 108, no. 5, pp. 1200–1207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  161. L. A. H. Haakstad, N. Voldner, T. Henriksen, and K. Bø, “Physical activity level and weight gain in a cohort of pregnant Norwegian women,” Acta Obstetricia et Gynecologica Scandinavica, vol. 86, no. 5, pp. 559–564, 2007. View at Publisher · View at Google Scholar · View at Scopus
  162. L. A. H. Haakstad, N. Voldner, T. Henriksen, and K. Bø, “Why do pregnant women stop exercising in the third trimester?” Acta Obstetricia et Gynecologica Scandinavica, vol. 88, no. 11, pp. 1267–1275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  163. G. S. Zavorsky and L. D. Longo, “Exercise guidelines in pregnancy: new perspectives,” Sports Medicine, vol. 41, no. 5, pp. 345–360, 2011. View at Publisher · View at Google Scholar · View at Scopus
  164. Royal College of Obstetricians and Gynecologists. Exercise in Pregnancy. RCOG, Statement. No4. 2006, http://www.rcog.org.uk/womens-health/clinical-guidance/exercise-pregnancy.
  165. T. Hayashi, J. F. P. Wojtaszewski, and L. J. Goodyear, “Exercise regulation of glucose transport in skeletal muscle,” American Journal of Physiology, vol. 273, no. 6, pp. E1039–E1051, 1997. View at Scopus
  166. S. Lund, G. D. Holman, O. Schmitz, and O. Pedersen, “Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 13, pp. 5817–5821, 1995. View at Publisher · View at Google Scholar · View at Scopus
  167. J. R. Zierath, T. S. Tsao, A. E. Stenbit, J. W. Ryder, D. Galuska, and M. J. Charron, “Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complementation,” Journal of Biological Chemistry, vol. 273, no. 33, pp. 20910–20915, 1998. View at Publisher · View at Google Scholar · View at Scopus
  168. B. Cheatham, C. J. Vlahos, L. Cheatham, L. Wang, J. Blenis, and C. R. Kahn, “Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation,” Molecular and Cellular Biology, vol. 14, no. 7, pp. 4902–4911, 1994. View at Scopus
  169. L. J. Goodyear, “AMP-activated protein kinase: a critical signaling intermediary for exercise-stimulated glucose transport?” Exercise and Sport Sciences Reviews, vol. 28, no. 3, pp. 113–116, 2000. View at Scopus
  170. A. Krook, M. Björnholm, D. Galuska et al., “Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients,” Diabetes, vol. 49, no. 2, pp. 284–292, 2000. View at Scopus
  171. J. A. Houmard, C. D. Shaw, M. S. Hickey, and C. J. Tanner, “Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in human skeletal muscle,” American Journal of Physiology, vol. 277, no. 6, pp. E1055–E1060, 1999. View at Scopus
  172. D. S. King, G. P. Dalsky, M. A. Staten, W. E. Clutter, D. R. Van Houten, and J. O. Holloszy, “Insulin action and secretion in endurance-trained and untrained humans,” Journal of Applied Physiology, vol. 63, no. 6, pp. 2247–2252, 1987. View at Scopus
  173. B. H. Goodpaster, A. Katsiaras, and D. E. Kelley, “Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity,” Diabetes, vol. 52, no. 9, pp. 2191–2197, 2003. View at Publisher · View at Google Scholar · View at Scopus
  174. V. A. Hughes, M. A. Fiatarone, R. A. Fielding et al., “Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance,” American Journal of Physiology, vol. 264, no. 6, pp. E855–E862, 1993. View at Scopus
  175. C. R. Bruce, A. D. Kriketos, G. J. Cooney, and J. A. Hawley, “Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes,” Diabetologia, vol. 47, no. 1, pp. 23–30, 2004. View at Publisher · View at Google Scholar · View at Scopus
  176. P. Poirier, A. Tremblay, T. Broderick, C. Catellier, G. Tancrède, and A. Nadeau, “Impact of moderate aerobic exercise training on insulin sensitivity in type 2 diabetic men treated with oral hypoglycemic agents: is insulin sensitivity enhanced only in nonobese subjects?” Medical Science Monitor, vol. 8, no. 2, pp. CR59–CR65, 2002. View at Scopus
  177. G. L. Dohm, “Invited review: regulation of skeletal muscle GLUT-4 expression by exercise,” Journal of Applied Physiology, vol. 93, no. 2, pp. 782–787, 2002. View at Scopus
  178. J. R. Zierath, “Invited review: exercise training-induced changes in insulin signaling in skeletal muscle,” Journal of Applied Physiology, vol. 93, no. 2, pp. 773–781, 2002. View at Scopus
  179. P. S. MacLean, D. Zheng, and G. L. Dohm, “Muscle glucose transporter (GLUT 4) gene expression during exercise,” Exercise and Sport Sciences Reviews, vol. 28, no. 4, pp. 148–152, 2000. View at Scopus
  180. I. Irrcher, P. J. Adhihetty, A. M. Joseph, V. Ljubicic, and D. A. Hood, “Regulation of mitochondrial biogenesis in muscle by endurance exercise,” Sports Medicine, vol. 33, no. 11, pp. 783–793, 2003. View at Publisher · View at Google Scholar · View at Scopus
  181. M. F. Mottola, “The role of exercise in the prevention and treatment of gestational diabetes mellitus,” Current Diabetes Reports, vol. 8, no. 4, pp. 299–304, 2008. View at Publisher · View at Google Scholar · View at Scopus
  182. J. J. Lehman, P. M. Barger, A. Kovacs, J. E. Saffitz, D. M. Medeiros, and D. P. Kelly, “Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis,” Journal of Clinical Investigation, vol. 106, no. 7, pp. 847–856, 2000. View at Scopus
  183. H. Liang and W. F. Ward, “PGC-1α: a key regulator of energy metabolism,” American Journal of Physiology, vol. 30, no. 4, pp. 145–151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  184. W. T. Garvey, L. Maianu, J. A. Hancock, A. M. Golichowski, and A. Baron, “Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM,” Diabetes, vol. 41, no. 4, pp. 465–475, 1992. View at Scopus
  185. O. Pedersen, J. F. Bak, P. H. Andersen et al., “Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity for NIDDM,” Diabetes, vol. 39, no. 7, pp. 865–870, 1990. View at Scopus
  186. F. Dela, T. Ploug, A. Handberg et al., “Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM,” Diabetes, vol. 43, no. 7, pp. 862–865, 1994. View at Scopus
  187. J. R. Zierath and H. Wallberg-Henriksson, “From receptor to effector: insulin signal transduction in skeletal muscle from type II diabetic patients,” Annals of the New York Academy of Sciences, vol. 967, pp. 120–134, 2002. View at Scopus
  188. J. P. Kirwan and M. Jing, “Modulation of insulin signaling in human skeletal muscle in response to exercise,” Exercise and Sport Sciences Reviews, vol. 30, no. 2, pp. 85–90, 2002. View at Scopus
  189. M. Ishiki and A. Klip, “Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners,” Endocrinology, vol. 146, no. 12, pp. 5071–5078, 2005. View at Publisher · View at Google Scholar · View at Scopus
  190. R. V. Farese, M. P. Sajan, and M. L. Standaert, “Atypical protein kinase C in insulin action and insulin resistance,” Biochemical Society Transactions, vol. 33, no. 2, pp. 350–353, 2005. View at Publisher · View at Google Scholar · View at Scopus
  191. C. Frøsig and E. A. Richter, “Improved insulin sensitivity after exercise: focus on insulin signaling,” Obesity, vol. 17, no. 3, pp. S15–S20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  192. C. B. Dugani and A. Klip, “Glucose transporter 4: cycling, compartments and controversies,” EMBO Reports, vol. 6, no. 12, pp. 1137–1142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  193. L. Jovanovic-Peterson, E. P. Durak, and C. M. Peterson, “Randomized trial of diet versus diet plus cardiovascular conditioning on glucose levels in gestational diabetes,” American Journal of Obstetrics and Gynecology, vol. 161, no. 2, pp. 415–419, 1989. View at Scopus
  194. G. N. Brankston, B. F. Mitchell, E. A. Ryan, and N. B. Okun, “Resistance exercise decreases the need for insulin in overweight women with gestational diabetes mellitus,” American Journal of Obstetrics and Gynecology, vol. 190, no. 1, pp. 188–193, 2004. View at Publisher · View at Google Scholar · View at Scopus
  195. P. Bung, R. Artal, N. Khodiguian, and S. Kjos, “Exercise in gestational diabetes: an optional therapeutic approach?” Diabetes, vol. 40, no. 2, pp. 182–185, 1991. View at Scopus
  196. American Diabetes Association, “Standards of medical care in diabetes—2008,” Diabetes Care, supplement 1, pp. s12-–s54, 2008.
  197. ACOG Committee Obstetric Practice, “ACOG Committee opinion. Number 267, January 2002: exercise during pregnancy and the postpartum period,” Obstetrics & Gynecology, vol. 99, pp. 171–13, 2002.
  198. M. D. Avery, A. S. Leon, and R. A. Kopher, “Effects of a partially home-based exercise program for women with gestational diabetes,” Obstetrics and Gynecology, vol. 89, no. 1, pp. 10–15, 1997. View at Publisher · View at Google Scholar · View at Scopus
  199. A. García-Patterson, E. Martín, J. Ubeda, M. A. María, A. de Leiva, and R. Corcoy, “Evaluation of light exercise in the treatment of gestational diabetes,” Diabetes Care, vol. 24, no. 11, pp. 2006–2007, 2001. View at Scopus
  200. B. L. Marks, A. Ward, D. H. Morris, J. Castellani, and J. M. Rippe, “Fat-free mass is maintained in women following a moderate diet and exercise program,” Medicine and Science in Sports and Exercise, vol. 27, no. 9, pp. 1243–1251, 1995. View at Scopus
  201. D. C. Nieman, J. M. Davis, D. A. Henson et al., “Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run,” Journal of Applied Physiology, vol. 94, no. 5, pp. 1917–1925, 2003. View at Scopus
  202. N. Erdei, Z. Bagi, I. Édes, G. Kaley, and A. Koller, “H2O2 increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in Type 2 diabetic mice,” American Journal of Physiology, vol. 292, no. 1, pp. H649–H656, 2007. View at Publisher · View at Google Scholar · View at Scopus
  203. C. Keller, A. Steensberg, H. Pilegaard et al., “Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content,” The FASEB Journal, vol. 15, no. 14, pp. 2748–2750, 2001. View at Scopus
  204. M. A. Febbraio and B. K. Pedersen, “Contraction-induced myokine production and release: is skeletal muscle an endocrine organ?” Exercise and Sport Sciences Reviews, vol. 33, no. 3, pp. 114–119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  205. B. K. Pedersen and M. A. Febbraio, “Point: interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis,” Journal of Applied Physiology, vol. 102, no. 2, pp. 814–819, 2007. View at Publisher · View at Google Scholar · View at Scopus
  206. A. Festa, R. D'Agostino, G. Howard, L. Mykkänen, R. P. Tracy, and S. M. Haffner, “Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS),” Circulation, vol. 102, no. 1, pp. 42–47, 2000. View at Scopus
  207. E. W. Petersen, A. L. Carey, M. Sacchetti et al., “Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro,” American Journal of Physiology, vol. 288, no. 1, pp. E155–E162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  208. G. van Hall, A. Steensberg, M. Sacchetti et al., “Interleukin-6 stimulates lipolysis and fat oxidation in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 7, pp. 3005–3010, 2003. View at Publisher · View at Google Scholar · View at Scopus
  209. E. Hopps, B. Canino, and G. Caimi, “Effects of exercise on inflammation markers in type 2 diabetic subjects,” Acta Diabetologica, vol. 48, pp. 183–189, 2011.
  210. L. Volpe, G. Di Cianni, C. Lencioni, I. Cuccuru, L. Benzi, and S. Del Prato, “Gestational diabetes, inflammation, and late vascular disease,” Journal of Endocrinological Investigation, vol. 30, no. 10, pp. 873–879, 2007. View at Scopus
  211. H. Zhang and C. Zhang, “Vasoprotection by dietary supplements and exercise: role of TNFα signaling,” Experimental Diabetes Research, vol. 2012, Article ID 972679, 6 pages, 2012. View at Publisher · View at Google Scholar
  212. S. A. Hopkins, J. C. Baldi, W. S. Cutfield, L. McCowan, and P. L. Hofman, “Effects of exercise training on maternal hormonal changes in pregnancy,” Clinical Endocrinology, vol. 74, no. 4, pp. 495–500, 2011. View at Publisher · View at Google Scholar · View at Scopus
  213. J. B. Ruige, J. M. Dekker, W. F. Blum et al., “Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study: the Hoorn study,” Diabetes Care, vol. 22, no. 7, pp. 1097–1104, 1999. View at Publisher · View at Google Scholar · View at Scopus
  214. P. W. Franks, I. S. Farooqi, J. Luan et al., “Does physical activity energy expenditure explain the between-individual variation in plasma leptin concentrations after adjusting for differences in body composition?” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 7, pp. 3258–3263, 2003. View at Publisher · View at Google Scholar · View at Scopus
  215. J. A. Houmard, J. H. Cox, P. S. MacLean, and H. A. Barakat, “Effect of short-term exercise training on leptin and insulin action,” Metabolism, vol. 49, no. 7, pp. 858–861, 2000. View at Publisher · View at Google Scholar · View at Scopus
  216. E. Herrera and H. Ortega-Senovilla, “Disturbances in lipid metabolism in diabetic pregnancy—are these the cause of the problem?” Best Practice & Research, vol. 24, no. 4, pp. 515–525, 2010. View at Scopus
  217. E. Sivan and G. Boden, “Free fatty acids, insulin resistance, and pregnancy,” Current Diabetes Reports, vol. 3, no. 4, pp. 319–322, 2003. View at Scopus
  218. S. Furukawa, T. Fujita, M. Shimabukuro et al., “Increased oxidative stress in obesity and its impact on metabolic syndrome,” Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752–1761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  219. L. P. Turcotte, E. A. Richter, and B. Kiens, “Increased plasma FFA uptake and oxidation during prolonged exercise in trained vs. Untrained humans,” American Journal of Physiology, vol. 262, no. 6, pp. E791–E799, 1992. View at Scopus
  220. R. J. Tunstall, K. A. Mehan, G. D. Wadley et al., “Exercise training increases lipid metabolism gene expression in human skeletal muscle,” American Journal of Physiology, vol. 283, no. 1, pp. E66–E72, 2002. View at Scopus
  221. H. A. Keizer, G. Schaart, N. N. Tandon, J. F. C. Glatz, and J. J. F. P. Luiken, “Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres,” Histochemistry and Cell Biology, vol. 121, no. 2, pp. 101–107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  222. S. Golbidi, S. A. Ebadi, and I. Laher, “Antioxidants in the treatment of diabetes,” Current Diabetes Reviews, vol. 7, pp. 106–125, 2011.
  223. S. Golbidi and I. Laher, “Antioxidant therapy in human endocrine disorders,” Medical Science Monitor, vol. 16, no. 1, pp. RA9–RA24, 2010. View at Scopus
  224. M. T. Coughlan, P. P. Vervaart, M. Permezel, H. M. Georgiou, and G. E. Rice, “Altered placental oxidative stress status in gestational diabetes mellitus,” Placenta, vol. 25, no. 1, pp. 78–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  225. M. T. Coughlan, M. Permezel, H. M. Georgiou, and G. E. Rice, “Repression of oxidant-induced nuclear factor-κB activity mediates placental cytokine responses in gestational diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 7, pp. 3585–3594, 2004. View at Publisher · View at Google Scholar · View at Scopus
  226. M. Lappas, M. Permezel, and G. E. Rice, “Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5627–5633, 2004. View at Publisher · View at Google Scholar · View at Scopus
  227. E. Peuchant, J. L. Brun, V. Rigalleau et al., “Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes,” Clinical Biochemistry, vol. 37, no. 4, pp. 293–298, 2004. View at Publisher · View at Google Scholar · View at Scopus
  228. U. Kamath, G. Rao, C. Raghothama, L. Rai, and P. Rao, “Erythrocyte indicators of oxidative stress in gestational diabetes,” Acta Paediatrica, vol. 87, no. 6, pp. 676–679, 1998. View at Publisher · View at Google Scholar · View at Scopus
  229. V. Toescu, S. L. Nuttall, U. Martin et al., “Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes,” Clinical Science, vol. 106, no. 1, pp. 93–98, 2004. View at Publisher · View at Google Scholar · View at Scopus
  230. N. Inoue, S. Ramasamy, T. Fukai, R. M. Nerem, and D. G. Harrison, “Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells,” Circulation Research, vol. 79, no. 1, pp. 32–37, 1996. View at Scopus
  231. J. Hollander, R. Fiebig, M. Gore et al., “Superoxide dismutase gene expression in skeletal muscle: fiber-specific adaptation to endurance training,” American Journal of Physiology, vol. 277, no. 3, pp. R856–R862, 1999. View at Scopus
  232. F. Moien-Afshari, S. Ghosh, M. Khazaei, T. J. Kieffer, R. W. Brownsey, and I. Laher, “Exercise restores endothelial function independently of weight loss or hyperglycaemic status in db/db mice,” Diabetologia, vol. 51, no. 7, pp. 1327–1337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  233. S. Sankaralingam, Y. Jiang, S. T. Davidge, and S. Yeo, “Effect of exercise on vascular superoxide dismutase expression in high-risk pregnancy,” American Journal of Perinatology, vol. 28, no. 10, pp. 803–810, 2011. View at Publisher · View at Google Scholar
  234. F. W. Wagey, “Pregnancy exercise increase enzymatic antioxidant in pregnant women,” Bali Medical Journal, vol. 1, pp. 36–39, 2012.